InvestorsHub Logo

Venture_Cap

09/17/20 7:24 PM

#117573 RE: 3X Charm #117566

Agreed on all. Confidence in status quo is weak.

eklab

09/17/20 10:25 PM

#117605 RE: 3X Charm #117566

In February 2020 the FDA saw the tests for Leronlimab from several hospitals of mild and seriously ill corona virus patients.

These human tests for covid 19, were only for that one disease, corona virus.

After examination of those hospital provided tests, the FDA was satisfied with the efficiency and safety of Leronlimab medication and promptly announced, that by mid July 2020 CYDY would be approved.

Mind you, this was only an approval for one disease, "Covid-19".


What ever negotiations with the FDA and agreement with Pourhassan at a later date must have confused every one, since they re-tested and added double cubic centimeters to Leronlimab and also tested for HIV.

How did that all happen???

Amatuer17

09/18/20 6:23 AM

#117622 RE: 3X Charm #117566

NP will increase authorized shares to 1 Billion and keep on issuing new shares.

He did not issue more when stock was above $4 - now he will issue at $2